Combined health risks of cigarette smoking and low levels of physical activity: a prospective cohort study in England with 12-year follow-up by Jackson, SE et al.
1Jackson SE, et al. BMJ Open 2019;9:e032852. doi:10.1136/bmjopen-2019-032852
Open access 
Combined health risks of cigarette 
smoking and low levels of physical 
activity: a prospective cohort study in 
England with 12- year follow- up
Sarah E Jackson   ,1 Jamie Brown,1 Michael Ussher,2 Lion Shahab,1 
Andrew Steptoe,1 Lee Smith3
To cite: Jackson SE, Brown J, 
Ussher M, et al.  Combined 
health risks of cigarette 
smoking and low levels of 
physical activity: a prospective 
cohort study in England with 
12- year follow- up. BMJ Open 
2019;9:e032852. doi:10.1136/
bmjopen-2019-032852
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
032852).
Received 11 July 2019
Revised 14 October 2019
Accepted 05 November 2019
1Department of Behavioural 
Science and Health, University 
College London, London, UK
2Population Health Research 
Institute, St George’s University 
of London, London, UK
3The Cambridge Centre for Sport 
and Exercise Sciences, Anglia 
Ruskin University, Cambridge, 
UK
Correspondence to
Dr Sarah E Jackson;  
 s. e. jackson@ ucl. ac. uk
Original research
© Author(s) (or their 
employer(s)) 2019. Re- use 
permitted under CC BY. 
Published by BMJ.
Strengths and limitations of this study
 ► This study represents the first effort comprehensive-
ly to examine the combined risks of smoking and 
low levels of physical activity in a large prospective 
cohort study.
 ► Adjustment for a range of relevant covariates took 
into account potential confounders of the associa-
tions between exposures and outcomes.
 ► Findings were robust to three sensitivity analyses 
taking different analytical approaches.
 ► Reliance on self- reported data introduced potential 
for bias.
 ► We did not model dynamic effects (ie, the impact 
of changes in smoking status and physical activity 
across the time period on disease outcomes) which 
may have masked some associations.
AbStrACt
Objectives To (1) estimate the combined risks of cigarette 
smoking and physical inactivity for chronic disease, 
disability and depressive symptoms and (2) determine 
whether risks associated with these behaviours are 
additive or synergistic.
Design and setting Longitudinal observational population 
study using data from Waves 2 (2004/2005) through 8 
(2016/2017) of the English Longitudinal Study of Ageing, 
a prospective study of community- dwelling older adults in 
England.
Participants 6425 men and women aged ≥52 years 
(mean (SD) 65.88 (9.34) years) at baseline.
Main outcome measures Smoking status (never, former, 
current) and level of physical activity (high, defined as 
moderate/vigorous physical activity (MVPA) more than 
once a week; low, defined as MVPA once a week or less) 
were self- reported at Wave 2 baseline. Self- rated health, 
limiting long- standing illness, chronic conditions (coronary 
heart disease (CHD), stroke, cancer, chronic lung disease) 
and depressive symptoms were reported in each biennial 
wave.
results Both smoking and low levels of physical activity 
were associated with increased risk of incident health 
problems over the 12- year follow- up period. Current 
smokers with low levels of physical activity had especially 
high risks of developing fair/poor self- rated health, CHD, 
stroke, cancer and chronic lung disease compared with 
highly active never smokers (adjusted relative risk range 
1.89–14.00). While additive effects were evident, tests of 
multiplicative interactions revealed no evidence of large 
synergistic effects of smoking and low physical activity 
(Bayes factor range 0.04–0.61), although data were 
insensitive to detect smaller effects.
Conclusions Among older adults in England, there was 
no evidence of large synergistic effects of smoking and 
low levels of physical activity on risk of developing chronic 
disease or depressive symptoms over 12 years. However, 
additive effects of smoking and low levels of physical 
activity were evident, underscoring the importance of each 
of these lifestyle risk behaviours for disease onset.
IntrODuCtIOn
Smoking and low levels of physical activity 
are among the leading causes of preventable 
morbidity and mortality worldwide.1 Each is 
associated with substantially increased risk 
of developing a host of chronic diseases, 
including coronary heart disease (CHD), 
cancer and chronic lung diseases.2–5 Quit-
ting smoking and taking up physical activity 
leads to improvements in overall health 
and longevity, even relatively late in life.2 6–8 
Associations between low levels of physical 
activity and poorer mental health outcomes, 
including depression and anxiety disorders, 
have consistently been reported,9 10 and 
physical inactivity (defined as not meeting 
the recommended physical activity guide-
lines for good health) appears to be causally 
related to mental health conditions.3 The 
evidence on smoking is mixed, with some 
studies suggesting that the association with 
poor mental health can largely be explained 
by common causes, such as genes that predis-
pose to both smoking and depression11 12 and 
others finding evidence for a causal relation-
ship.13 14
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The combined health risks associated with smoking 
and physical inactivity have not been comprehen-
sively examined. This is important because health risk 
behaviours tend to cluster within individuals.15–17 Studies 
in large, representative samples have shown the majority 
of adults in England and the USA have multiple lifestyle 
risk factors (eg, smoking, physical inactivity, excessive 
alcohol intake, low fruit and vegetable consumption),15 17 
and there is evidence to suggest that combinations of life-
style risk factors have a greater adverse impact on health 
than would be expected from the added individual effects 
alone.18–22 If lifestyle risk factors work synergistically (ie, 
greater than the sum of the risks associated with each 
behaviour individually, indicating the behaviours act as 
effect modifiers for each other) rather than additively 
(ie, the combined risk is greater than the individual risks 
associated with each behaviour) to influence disease 
risk, there may be potential to increase the public health 
impact of behavioural change interventions by targeting 
multiple behaviours.23–25 However, the extant literature 
on the benefits of multiple behavioural change interven-
tions is mixed, and their effectiveness likely depends on 
particular behavioural combinations and whether there 
is genuine synergy between them.24 A Cochrane review of 
randomised controlled trials (RCTs) of physical activity 
in addition to smoking cessation treatment found mixed 
results, with the majority failing to provide evidence that 
physical activity aids smoking cessation.26 However, most 
of these trials had small samples or a physical activity 
component insufficiently intense to achieve the desired 
level of activity.26 Examination of the risks associated with 
smoking and physical activity in combination is important 
to determine synergistic health effects of these risk factors 
and evaluate the potential usefulness of further research 
targeting this combination of behaviours in interventions 
for primary prevention.
There is some evidence from cross- sectional studies to 
suggest smoking and physical activity interact to influence 
the risk of adverse physical and mental health outcomes. 
For example, in a large sample of adult smokers, physical 
activity was found to moderate the association between 
nicotine dependence and depression.27 The results indi-
cated smokers with high nicotine dependence and low 
physical activity were more likely to be depressed than 
would be expected on the basis of individual effects of 
smoking and physical inactivity. Similarly, a survey of under-
graduate smokers found that those with a lower level of 
physical activity had higher odds of depression.28 However, 
the cross- sectional study design makes it very difficult to 
interpret the direction of associations. For example, it is 
possible being depressed leads to the uptake of smoking 
and a loss of interest in physical activity, as opposed to 
being the result of these behaviours. A number of RCTs 
have examined the impact of physical activity on smoking 
and cessation outcomes, and provided strong evidence 
that exercise reduces nicotine cravings and withdrawal 
symptoms,26 29 30 although a positive impact on relapse 
has not clearly been demonstrated.31 Regarding physical 
health effects, the evidence is mixed. For example, two 
small experimental studies have examined the impact of 
physical activity on cardiovascular biomarkers in smokers 
and observed improvements in the cardiovascular risk 
profile over 3 months.32 33 A cohort study of adults in 
Copenhagen followed for an average of 11 years found 
that smokers who engaged in moderate to high levels of 
regular physical activity experienced a smaller decline 
in lung function decline and lower chronic obstructive 
pulmonary disease risk than those who were less active.34 
However, another study that followed middle- aged men 
in Japan over a similar duration observed no significant 
interaction between smoking status and level of physical 
activity for risk of pancreatic cancer.35 To the best of our 
knowledge, no studies have evaluated synergistic effects 
of smoking and physical activity on depression or chronic 
disease in a large, representative sample using a prospec-
tive design.
Using data collected over 12 years from a large 
population- based sample of older adults living in England, 
this study therefore aimed to examine the risks of chronic 
disease and poor mental health associated with cigarette 
smoking and low levels of physical activity combined. 
Specifically, we aimed to answer the following research 
questions:
1. To what extent is the combination of smoking and 
low physical activity associated with increased risk of 
the incidence of poor self- rated health, limiting long- 
standing illness, CHD, stroke, cancer, chronic lung 
disease and depressive symptoms over 12- year follow- 
up among older adults who are healthy at baseline, 
over and above the risks associated with smoking or 
low physical activity alone, or neither smoking nor low 
physical activity?
2. Are the combined risks of smoking and low physical 
activity for these outcomes additive or synergistic?
MethOD
Design
This investigation used data from the English Longitu-
dinal Study of Ageing (ELSA) covering a 12- year period. 
ELSA is a population- based longitudinal panel study of a 
representative sample of men and women aged 50 and 
older living in England. The study began in 2002 (Wave 1), 
with participants recruited from an annual cross‐sectional 
survey of households. Data are collected every 2 years via 
computer- assisted personal interview and self- completion 
questionnaires. In alternate (even) waves there is an addi-
tional health examination, in which objective measures 
are obtained. For the present study, baseline data were 
drawn from Wave 2 (2004/2005; the first wave in which 
height and weight were measured, allowing inclusion of 
body mass index (BMI) in the analyses), collected when 
participants were aged ≥52 years. Follow- up data were 
collected biennially through to Wave 8 (2016/2017; the 
most recent wave of available data).
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Measures
Measurement of exposures
Smoking status was defined as current, former or never 
smoker on the basis of responses to two yes/no ques-
tions: (1) “Have you ever smoked cigarettes?” (2) “Do you 
smoke cigarettes at all nowadays?” This measure has been 
validated against salivary cotinine levels in the Health 
Survey for England.36
Physical activity was assessed with three items that asked 
participants how often they took part in activities that 
were vigorous (eg, jogging, cycling), moderately ener-
getic (eg, gardening, walking at moderate pace) or mildly 
energetic (eg, laundry, home repairs). Response options 
were: more than once a week, once a week, 1–3 times a 
month, hardly ever/never. Activity examples provided to 
respondents correspond to metabolic equivalent of task 
≥6, ≥3.5 to<6 and ≥2 to<3.5, respectively, for vigorous, 
moderate and mild activities. For the purpose of analysis, 
we categorised physical activity into two categories: high 
physical activity (moderate and/or vigorous activity more 
than once a week) versus low physical activity (moderate/
vigorous activity once a week or less). This measure has 
been validated against objective, accelerometer- measured 
hours of moderate–vigorous intensity activity and demon-
strates convergent validity in grading a wide range of 
psychosocial, physical and biochemical outcomes.7 37–41
Measurement of outcomes
We included as outcomes two measures of subjective 
health (self- rated health, limiting long- standing illness), 
four diagnosed chronic conditions (CHD, stroke, cancer, 
chronic lung disease) and one measure of mental health 
(clinically relevant depressive symptoms).
Self‐rated health was assessed using a single item: 
‘Would you say your health is … poor/fair/good/very 
good/excellent?’ We analysed the proportion of individ-
uals rating their health as fair/poor, as has been done in 
previous investigations.42–44
We also used data on self- reported limiting long- 
standing illness, which reflects the extent to which partic-
ipants feel their daily activities are limited by the presence 
of illness. This was assessed with two questions: (1) ‘Do 
you have any long- standing illness, disability or infirmity? 
By long- standing I mean anything that has troubled you 
over a period of time or that is likely to affect you over a 
period of time.’ Those who responded yes were asked: (2) 
‘Does this illness or disability limit your activities in any 
way?’ Affirmation of a long- standing illness and any form 
of limitation classified the participant as having a limiting 
long- standing illness.
Doctor- diagnosed CHD, stroke, cancer and chronic 
lung disease were self- reported in response to presenta-
tion of a list of conditions and the question: ‘Has a doctor 
ever told you that you have (or have had) any of the 
conditions on this card?’
Depressive symptoms were assessed with an eight- item 
version of the Center for Epidemiologic Studies Depres-
sion Scale, a validated instrument for use in older adults.45 
Respondents were asked to indicate whether they had 
experienced depressive symptoms (eg, restless sleep 
and being unhappy) over the past month using a binary 
(yes/no) response. Total scores ranged from 0 to 8, with 
higher scores indicating more depressive symptoms. 
Data were dichotomised using an established cut‐off, 
with a score of 4 or higher indicating clinically relevant 
symptomatology.46
For each outcome of interest, we analysed the propor-
tion of participants free from that outcome at Wave 2 
baseline who reported the presence of the outcome in 
Wave 3, 4, 5, 6, 7 or 8 (coded 1). Therefore, our depen-
dent variables incorporated all new- onset adverse health 
outcomes reported by participants across the 12- year 
follow- up period. For our primary analyses, participants 
retained in the study at Wave 8 who did not report the 
presence of the outcome in any wave were coded 0. Partic-
ipants lost to follow- up before Wave 8 who did not report 
the presence of the outcome in any wave were coded as 
missing, because it was not possible to determine their 
status.
Measurement of covariates
Demographic variables included baseline age, sex and 
ethnicity (white vs non- white). Sociodemographic posi-
tion was indexed using household non- pension wealth, 
which has been identified as a particularly sensitive indi-
cator in this population.47 Past- year alcohol intake was 
categorised as never/rare (never—once or twice a year), 
regular but infrequent (once every couple of months—
twice a week) or frequent (3 days a week—almost every 
day). BMI was calculated as weight in kilograms/height in 
metres squared based on objective measurements.
Statistical analysis
The analysis plan was preregistered on Open Science 
Framework (https:// osf. io/ g9p2b/). We amended our 
prespecified definition of physical activity categories on 
seeing the distribution of the data, because our original 
dichotomy of moderate/vigorous physical activity at least 
once a week resulted in an implausibly high proportion 
of the sample being classified as high active (~80%). For 
transparency, results based on the original categorisation 
are available on Open Science Framework.
We used one- way independent analyses of variance 
(continuous variables) and Pearson’s χ2 tests (categorical 
variables) to analyse differences in baseline characteris-
tics by smoking status (never/former/current) and level 
of physical activity (high/low).
We used log- binomial regression to calculate the rela-
tive risks (RRs) with 95% CIs associated with smoking and 
physical activity of incident fair/poor self- rated health, 
limiting long- standing illness, CHD, stroke, cancer, 
chronic lung disease and depressive symptoms over 
12- year follow- up among participants who did not report 
the outcome of interest at baseline. We constructed five 
models for each outcome. The first and second calculated 
unadjusted RRs associated with smoking status (reference 
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category: never smoker) and physical activity (reference 
category: high active), respectively. The third tested main 
effects of smoking status and physical activity, and the 
multiplicative interaction between smoking status and 
physical activity, controlling for covariates. The fourth 
and fifth calculated unadjusted and adjusted RRs, respec-
tively, associated with each combination of smoking status 
and level of physical activity: (1) never smoker/high 
active (reference category), (2) never smoker/low active, 
(3) former smoker/high active, (4) former smoker/low 
active, (5) current smoker/high active and (6) current 
smoker/low active.
We performed three sensitivity analyses. The first 
imputed missing outcomes data for those who dropped 
out of ELSA before Wave 8 and did not report the pres-
ence of any of these conditions in their completed waves. 
A multiple imputation model was run with all exposures 
and covariates entered as predictors. Five imputed data-
sets were created, each was analysed separately and the 
results were combined to produce pooled estimates 
of effects. The second sensitivity analysis restricted the 
sample to those with complete data at Wave 2 and Wave 
8 to assess healthy survivor effects. The third excluded 
current smokers who smoke <15 cigarettes per day (indic-
ative of a lower level of nicotine dependence) to address 
the potential issue of differential rates of smoking cessa-
tion in relation to level of physical activity.48 One would 
expect a lower rate of successful quitting during the 
follow- up period among more dependent smokers, so it 
was thought that excluding those who were less depen-
dent may provide a better reflection of the combined 
health risks of smoking and low physical activity rather 
than an artefact of more successful quitting among active 
smokers generally.
To evaluate the extent to which our data supported the 
null hypothesis (ie, no synergistic relationship between 
smoking and physical activity for risk of incident health 
problems), the experimental hypothesis (ie, synergy 
between smoking and physical activity) or were insen-
sitive, we calculated Bayes factors (BFs) for the multi-
plicative interaction results (see online supplementary 
material for details).
All analyses were conducted in SPSS V.24, with the 
exception of the BFs which were calculated using an 
online calculator (http://www. lifesci. sussex. ac. uk/ 
home/ Zoltan_ Dienes/ inference/ Bayes. htm).
Public and patient involvement
No patients were involved in setting the research ques-
tions or outcome measures, nor were they involved in the 
design and implementation of the study. There are no 
plans to involve patients in dissemination.
reSultS
Sample characteristics
There were 9432 individuals in Wave 2 of ELSA, of whom 
7666 (81.3%) participated in the health examination in 
which objective measurements of height and weight were 
obtained. We excluded 1241 individuals (16.2%) with 
missing data, leaving a final sample for analysis of 6425 
participants. Compared with those who were excluded, 
the analysed sample had a similar mean age but were 
more likely to be male, white and wealthier. They were 
also more likely to drink alcohol regularly or frequently 
and had a higher mean BMI, but were less likely to smoke 
or have low physical activity. The prevalence of chronic 
disease and depressive symptoms was generally lower in 
the analysed sample (online supplementary table 1).
Table 1 presents descriptive characteristics measured at 
Wave 2 baseline overall and by smoking status and level 
of physical activity. The sample comprised 2902 men and 
3523 women aged ≥52 years (mean (SD) 65.88 (9.34) 
years). Participants were predominantly white (98.8%) 
and the upper quintiles of wealth were over- represented. 
The majority (81.1%) reported regular or frequent 
alcohol intake and the mean BMI was in the overweight 
range (27.91 (4.87) kg/m2). The prevalence of chronic 
disease and depressive symptoms ranged from 2.4% 
(stroke) to 32.9% (limiting long- standing illness).
Some 14.0% of participants were current smokers, 
48.9% were former smokers and 37.2% were never 
smokers. Those who reported current smoking tended to 
be younger than never/former smokers, and more were 
from the lower quintiles of wealth. Current and former 
smokers were more likely than never smokers to be 
female and white. Former smokers were the most likely to 
report drinking alcohol frequently and had the highest 
BMI. Current smokers were the most likely to have low 
levels of physical activity. They were also more likely than 
former and never smokers to rate their health as fair or 
poor, and to report the presence of limiting long- standing 
illness, diagnosed chronic lung disease and clinically rele-
vant depressive symptoms. Former smokers were the most 
likely to report CHD and stroke.
Just over a third (34.1%) were classified as having low 
physical activity. Relative to those with high levels of phys-
ical activity, participants with low levels of physical activity 
were older on average, and a higher proportion were 
female and from the lower quintiles of wealth (table 1). 
They were less likely to drink alcohol frequently, had a 
higher mean BMI and were more likely to be current 
smokers. Participants with low levels of physical activity 
were also more likely than those with high levels of phys-
ical activity to rate their health as fair or poor, and to 
report the presence of a limiting long- standing illness, 
diagnosed CHD, stroke, cancer or chronic lung disease, 
and clinically relevant depressive symptoms.
Associations with incident health problems
For each outcome, table 2 summarises the absolute risk 
and unadjusted and adjusted RRs associated with smoking 
status and physical activity, and interactions between 
smoking status and physical activity. Table 3 shows the 
absolute risk and unadjusted and adjusted RRs associated 
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with each combination of smoking status and physical 
activity.
Main effects of smoking status
In unadjusted models (table 2), both former and current 
smokers had significantly higher risks of developing fair/
poor self- rated health, CHD and chronic lung disease 
than never smokers (RR range 1.20–2.34 for former 
smokers, RR range 1.45–6.28 for current smokers). Risk 
of stroke was significantly higher among current smokers 
than never smokers (RR 1.58), but did not differ signifi-
cantly between former and never smokers (RR 1.22). 
Smoking status was not significantly associated with the 
risk of developing a limiting long- standing illness, cancer 
or clinically relevant depressive symptoms (RR range 
1.10–1.28).
After adjustment for age, sex, ethnicity, wealth, alcohol 
intake, BMI and level of physical activity (table 2), the risk 
of developing chronic lung disease remained significantly 
higher among former (adjusted relative risk (RRadj 2.77) 
and current smokers (RRadj 8.33), and risks of developing 
fair/poor self- rated health, CHD and stroke were signifi-
cantly higher among current smokers (RRadj range 1.55–
1.93), relative to never smokers. The risk of developing 
cancer approached statistical significance for current 
versus never smokers (RRadj 1.44).
Main effects of physical activity
In unadjusted models (table 2), participants with low 
physical activity had significantly higher risks of devel-
oping fair/poor self- rated health, limiting long- standing 
illness, CHD, stroke, cancer, chronic lung disease and 
clinically relevant depressive symptoms than those with 
high physical activity (RR range 1.19–2.67).
After adjustment for age, sex, ethnicity, wealth, alcohol 
intake, BMI and smoking status (table 2), the risk of devel-
oping chronic lung disease remained significantly higher 
among those with low versus high physical activity (RRadj 
3.50), but other associations were attenuated and became 
non- significant (RRadj range 1.06–1.40).
Additive and synergistic effects of smoking status and physical 
activity
After adjustment for covariates, significant differences 
in risks of developing fair/poor self- rated health, CHD, 
stroke, cancer and chronic lung disease were observed 
across different combinations of smoking status and levels 
of physical activity (table 3, figure 1).
Relative to never smokers with high physical activity, 
current smokers with low physical activity had the highest 
risks of each of these outcomes (RRadj range 1.89–14.00). 
Risks of fair/poor self- rated health, CHD, stroke and 
chronic lung disease were also significantly elevated 
among current smokers with high physical activity (RRadj 
range 1.55–8.33), and the risk of cancer approached 
significance (RRadj 1.44), although RRs were lower than 
those for current smokers with low physical activity.
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Figure 1 Relative risks of developing (A) fair/poor self- rated health, (B) limiting long- standing illness, (C) coronary heart 
disease, (D) stroke, (E) cancer, (F) chronic lung disease and (G) clinically relevant depressive symptoms over 12- year follow- up 
by baseline smoking/physical activity status, among older adults free of these conditions at baseline.
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Risks of fair/poor self- rated health, CHD, cancer and 
chronic lung disease were also significantly elevated for 
those with low physical activity who had stopped smoking, 
although risks relative to never smokers with high phys-
ical activity were comparatively lower than were observed 
for current smokers (RRadj range 1.35–5.42). Chronic 
lung disease was the only outcome for which significantly 
elevated risk was observed among former smokers with 
high physical activity (RRadj 2.77) or never smokers with 
low physical activity (RRadj 3.50), relative to never smokers 
with high physical activity.
The risks of limiting long- standing illness and clinically 
relevant depressive symptoms did not differ significantly 
across smoking/physical activity groups, although point 
estimates followed a similar pattern (table 3, figure 1).
While additive effects were evident, with the health 
risks associated with the combination of current smoking 
and low physical activity higher than those associated with 
one or other of these behaviours in isolation (table 3, 
figure 1), tests of multiplicative interactions revealed 
no evidence of synergistic effects of smoking and low 
physical activity (table 2). The only outcome for which 
the interaction approached statistical significance was 
chronic lung disease (p=0.070), where the effect was in 
the opposite direction to what we hypothesised, that is, 
relative to never smokers, the increase in risk associated 
with inactivity appears smaller in current smokers.
BFs based on large synergistic effects between smoking 
status and physical activity indicated the data provided 
strong evidence for the null hypothesis for chronic lung 
disease and moderate evidence for the null hypothesis 
for incident fair/poor self- rated health, limiting long- 
standing illness, cancer and depressive symptoms, but 
were insensitive to detect large effects for CHD and 
stroke (see online supplementary table 2). BFs based on 
medium and small synergistic effects favoured the null 
hypothesis but indicated the data were insensitive for all 
outcomes except chronic lung disease.
Sensitivity analyses
Sensitivity analyses taking three different analytical 
approaches produced a very similar pattern of results (see 
online supplementary material, tables 3–5 and figures 
1–3 for full details).
DISCuSSIOn
In this large prospective study of older adults, we exam-
ined the risks of incident self- rated health, limiting 
long- standing illness, CHD, stroke, cancer, chronic lung 
disease and depressive symptoms over 12- year follow- up 
associated with smoking and low levels of physical activity 
among individuals free of these conditions at baseline. 
We observed additive effects of smoking and low phys-
ical activity on these outcomes, with older adults who 
reported both current smoking and low physical activity 
at higher risk of developing these conditions than those 
who engaged in one or neither of these lifestyle risk 
behaviours. However, there was no evidence of synergistic 
effects of smoking and low physical activity on the inci-
dence of these conditions.
It has been proposed that targeting multiple behaviours 
could increase the public health impact of behavioural 
change interventions,23–25 but evidence on the effective-
ness of this strategy is inconsistent.24 For example, studies 
focusing on physical activity and diet have shown interven-
tions that focus on a single behaviour are more effective 
in increasing the target behaviours, while those that target 
both behaviours result in greater weight loss.49 Dieting 
while trying to stop smoking is associated with worse 
smoking outcomes,50 and it is generally recommended 
smokers do not attempt to diet until several months after 
quitting.50 It is likely that the effectiveness of multiple 
behavioural change interventions relies on there being 
a synergistic relationship between the target behaviours. 
The failure of the present study to find evidence of 
synergy between smoking and low physical activity on 
risk of chronic disease and depressive symptoms suggests 
targeting this combination of behaviours is unlikely to be 
more effective in reducing the risk of these adverse health 
outcomes than focusing on each behaviour separately. 
This is consistent with findings of RCTs that have exam-
ined effects of physical activity as an adjunct to smoking 
cessation treatment. A 2014 Cochrane review26 identified 
20 RCTs (total n=5870) that compared an exercise- only 
intervention or a combined exercise and smoking cessa-
tion intervention with a cessation only intervention. Just 
2 of the 20 trials found a beneficial effect of including an 
exercise component on long- term cessation.26
However, despite the lack of evidence for synergy 
between these behaviours, there are other reasons why 
targeting smoking and physical activity in a multiple 
behavioural change intervention may be beneficial. 
For example, changes in physical activity as a result of 
an intervention may interact differently with smoking 
compared with more spontaneous changes in physical 
activity (as reported in cohort studies) and especially so if 
the intervention is actively used to promote cessation (eg, 
as a means for reducing cigarette cravings30). It is also 
possible that smoking and physical activity may interact in 
different ways depending on the timing of changes in the 
two behaviours.51
While the present results provide no evidence for 
synergistic effects of smoking and low physical activity 
on health, there were clear additive effects. Current 
smokers were at higher risk of incident health problems 
than former or never smokers. People with low physical 
activity were at higher risk of incident health problems 
than those who engaged in regular moderate/vigorous 
intensity physical activity. The combination of current 
smoking and low physical activity conferred the highest 
risk of each outcome: notably, individuals who reported 
both behaviours had more than twice the risk of devel-
oping CHD, three times higher risk of having a stroke 
and 14 times higher risk of developing chronic lung 
disease over 12- year follow- up than never smokers who 
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engaged in regular physical activity. These results empha-
sise the importance of promoting both abstinence from 
smoking and regular physical activity, and intervening to 
encourage behavioural change for people with unhealthy 
lifestyles.
This study had several strengths. The sample was drawn 
from a large, nationally representative cohort of older 
adults. The prospective design facilitated assessment of 
the temporal relationship between smoking and physical 
inactivity and future disease onset. Assuming the health 
risk behaviours have a cumulative (dose–response) effect 
on health outcomes, the older age of the sample meant 
we had a better chance of detecting an effect given longer 
exposure in this population group. Adjustment for a 
range of relevant covariates took into account potential 
confounders of the associations between exposures and 
outcomes. Findings were robust to three sensitivity anal-
yses taking different analytical approaches.
There were also a number of limitations. First, the 
items used to assess smoking status did not specify regular 
smoking, meaning the group of former smokers encom-
passed a wide range of smoking histories, from very occa-
sional use to heavy smoking. As such, our results may 
underestimate the health risks associated with former 
(regular) smoking. Second, physical activity was self- 
reported, introducing scope for bias. A recent study docu-
mented notable discrepancy between objective measures 
and self- reports of physical activity, including an age- 
related decline in activity levels captured by accelerom-
etery that was not observed in self- reports.52 In addition, 
levels of physical activity were dichotomised for analysis, 
distinguishing between those who engaged in moderate 
or vigorous activities more than once a week and those 
who engaged in less frequent moderate or vigorous activ-
ities. Replication of these analyses using a more objective 
and detailed measure of physical activity would be useful 
in validating our results. Third, chronic disease outcomes 
were based on self- reports of doctor diagnosis, and it is 
possible some may have been forgotten or not reported. 
However, validation studies comparing self- reports against 
medical records generally show high agreement.53 Fourth, 
while we included participants who reported the onset 
of health problems in any wave, regardless of whether 
they were retained in ELSA through to final follow- up 
at Wave 8, we excluded from our primary analyses those 
who did not report health problems or depressive symp-
toms prior to dropout. This group likely included indi-
viduals suffering from the conditions we were studying, 
but who died before the diseases were identified or could 
be reported in an ELSA interview. As such, our results 
may underestimate the impact of our exposures on the 
health outcomes of interest, although a sensitivity anal-
ysis based on imputed data produced similar estimates 
of associations. There were several differences between 
the analysed sample and participants we excluded, 
with the analysed sample generally more advantaged, 
healthier and less likely to smoke or have low levels of 
physical activity. As such, our results may not generalise 
to the entire older population in England. Insofar that 
a synergistic effect of smoking and low physical activity is 
greater in less advantaged groups, then the current study 
could have underestimated the overall effect. In addi-
tion, we did not model dynamic effects (ie, the impact 
of changes in smoking status and physical activity across 
the time period on disease outcomes) which may have 
masked some associations, although previous analyses of 
the ELSA cohort suggest that smoking status and level 
of physical activity remain stable across waves for the 
majority of participants.54 Fifth, although we had a large 
sample, the number of incident diagnoses was relatively 
small meaning we likely lacked statistical power to detect 
significant effects. Indeed, BFs indicated that while the 
data supported the null hypothesis (ie, no synergistic 
effects of smoking and physical activity), there was some 
data insensitivity which meant we were unable to rule out 
small- sized and medium- sized effects. The small number 
of incident cases also meant we were unable to conduct 
more fine- grained analyses, for example focusing on 
specific cancer types (eg, lung, breast, colorectal) that 
might be affected by the exposures. Finally, while we 
adjusted for a range of potential confounders, there 
were no data available on substance misuse (aside from 
alcohol intake, which we controlled for) or diet quality. 
These variables have been associated to varying degrees 
with our exposures15–17 55 and outcomes of interest.56–59 
Further research is required to validate our findings with 
adjustment for these variables. There is also potential for 
residual confounding by socioeconomic position if there 
were aspects of this that were not accounted for by our 
adjustment for non- pension wealth.
COnCluSIOnS
The present results are not suggestive of large syner-
gistic effects of smoking and low levels of physical activity 
on risk of developing chronic disease or clinically rele-
vant depressive symptoms (although smaller synergistic 
effects cannot be ruled out). However, additive effects of 
smoking and low activity were evident, underscoring the 
importance of each of these behaviours for disease onset.
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